warning: Parameter 2 to flowplayer3_swftools_flashvars() expected to be a reference, value given in /var/www/pressflow/includes/module.inc on line 450.
1 in 5 Hip Implant Recipients May Be Subject to Recall

According to a market research study prepared by GlobalData, in 2009 DePuy held a 21% market share of the global hip and knee replacement market. This leads to the conclusion that as many 1 in 5 hip implant recipients have had DePuy devices installed and are now subject to the recall. Read more »

Filed under:
DePuy Hip Replacement Recall DePuy Orthopaedics is voluntarily recalling its ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System. This recall means additional testing and treatment may be necessary to ensure the hip is functioning well. In some cases, patients may need additional surgery. Call our DePuy Hip Implant lawyers for a free DePuy Hip Implant claim evaluation, (877) 917-5250 Continue ⇒
Filed under:

Lawsuits of Interest

Accutane  (isotretinoin)
Advair  (Fluticasone/salmeterol)
Avandia  (Rosiglitazone)
Bextra  (Valdecoxib)
Celebrex  (Celecoxib)
Chantix  (Varenicline)
Digitek  (Digoxin)

Fill out this form for a free evaluation:
Please type your name.
Please type your email address.
Please select the cause of your injury.
Enter any information that you would lke us to know.